BSHT 2023: HMB-001 - a novel bispecific antibody accumulating and targeting endogenous FVIIa to activated platelets supports enhanced haemostatic responses in models of Glanzmann’s thrombasthenia
Presented at the 2023 British Society for Haemostasis & Thrombosis (BSHT) Annual Scientific Meeting
To view presentation, click here